| ||
| ||
|
| ||
| Peregrine says lung cancer drug extended survival - BusinessWeek Peregrine Pharmaceuticals Inc. said Wednesday that lung cancer patients treated with its drug candidate bavituximab lived for an average of 12.4 months, ... www.businessweek.com/ap/financialnews/D9NSE9V80.htm | ||
| Study: Pfizer lung cancer pill may double survival - WTOC ... WTOC.com, the Southeast News Leader, news, weather and sports for Savannah, Georgia, the Coastal Empire and South Carolina Lowcountry. www.wtoc.com/Global/story.asp?S=14841899 | ||
| New lung cancer drug may boost survival - WOOD-TV US Bulletin is a financial news and information web portal. Obtain up to date financial news from sources around the globe. latestbusinessreport.com/.../652548-new-lung-cancer-drug-ma... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment